587 related articles for article (PubMed ID: 18325087)
1. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
[TBL] [Abstract][Full Text] [Related]
3. Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.
Sparks JA; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):512-520. PubMed ID: 29799667
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.
Innala L; Möller B; Ljung L; Magnusson S; Smedby T; Södergren A; Öhman ML; Rantapää-Dahlqvist S; Wållberg-Jonsson S
Arthritis Res Ther; 2011 Aug; 13(4):R131. PubMed ID: 21843325
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis.
Cacciapaglia F; Fornaro M; Venerito V; Perniola S; Urso L; Iannone F
Eur J Clin Invest; 2020 Dec; 50(12):e13343. PubMed ID: 32654116
[TBL] [Abstract][Full Text] [Related]
7. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
8. Disease activity in rheumatoid arthritis and the risk of cardiovascular events.
Solomon DH; Reed GW; Kremer JM; Curtis JR; Farkouh ME; Harrold LR; Hochberg MC; Tsao P; Greenberg JD
Arthritis Rheumatol; 2015 Jun; 67(6):1449-55. PubMed ID: 25776112
[TBL] [Abstract][Full Text] [Related]
9. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
[TBL] [Abstract][Full Text] [Related]
10. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Baghdadi LR; Woodman RJ; Shanahan EM; Mangoni AA
PLoS One; 2015; 10(2):e0117952. PubMed ID: 25689371
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
12. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.
Solomon DH; Curtis JR; Saag KG; Lii J; Chen L; Harrold LR; Herrinton LJ; Graham DJ; Kowal MK; Kuriya B; Liu L; Griffin MR; Lewis JD; Rassen JA
Am J Med; 2013 Aug; 126(8):730.e9-730.e17. PubMed ID: 23885678
[TBL] [Abstract][Full Text] [Related]
14. Rheumatologists, take heart! We may be doing something right.
van Vollenhoven RF
Arthritis Res Ther; 2008; 10(2):105. PubMed ID: 18341711
[TBL] [Abstract][Full Text] [Related]
15. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
16. Biologic Agents Reduce Cardiovascular Events in Rheumatoid Arthritis Not Responsive to Tumour Necrosis Factor Inhibitors: A National Cohort Study.
Hsieh MJ; Lee CH; Tsai ML; Kao CF; Lan WC; Huang YT; Tseng WY; Wen MS; Chang SH
Can J Cardiol; 2020 Nov; 36(11):1739-1746. PubMed ID: 32603700
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
Kaushik P; Solomon DH; Greenberg JD; Anderson JT; Reed G; Pala O; Sumbul-Yuksel B; Kadam P; Kremer JM;
Clin Rheumatol; 2015 Oct; 34(10):1697-704. PubMed ID: 26242470
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
[TBL] [Abstract][Full Text] [Related]
19. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Ocon AJ; Reed G; Pappas DA; Curtis JR; Kremer JM
Ann Rheum Dis; 2021 Dec; 80(12):1522-1529. PubMed ID: 34215644
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events.
Gouze H; Aegerter P; Said-Nahal R; Zins M; Goldberg M; Morelle G; Schett G; Breban M; D'Agostino MA
Arthritis Res Ther; 2022 Feb; 24(1):56. PubMed ID: 35209936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
